Davidson Memory Clinic

Moncton, New Brunswick E1C 4B7

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Parkinson Disease

Studies at this site

• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed
• Effects of ONO-2506PO in Patients With Alzheimer's Disease — Completed
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed